Why did Trump double steel and aluminum tariffs?
How are tariffs impacting US retailers’ profits?
What caused $14B in EV and renewable projects cancellation?
Why is JPMorgan dimon warning about bond market cracks?
How did Tesla's robotaxi rollout alarm the public?
Why is the EU threatening countermeasures after US tariffs?
What’s behind Meta’s plan to replace humans with AI?
PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate
benzinga.com/25/05/45669058/pepgen-abandons-duchenne-program-shifts-spotlight-to-another-rare-disease-candidate
PepGen Inc. (NASDAQ:PEPG) announced on Wednesday that it will focus on advancing its myotonic dystrophy type 1 (DM1) program, currently in Phase 2 clinical development.
The company voluntarily discontinued the development of PGN-EDO51 and intends to wind down all Duchenne muscular…
This story appeared on benzinga.com, 2025-05-29 13:19:53.